High cholesterol causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 11: | Line 11: | ||
{{col-begin|width=80%}} | {{col-begin|width=80%}} | ||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
* | *[Apo A-I deficiency]] | ||
*[[ | *[[Berardinelli–seip syndrome ]] | ||
*[[Diabetes mellitus]] | *[[Diabetes mellitus]] | ||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
*[[Hashimoto's thyroiditis ]] | *[[Hashimoto's thyroiditis ]] | ||
*[[Metabolic syndrome ]] | *[[Metabolic syndrome ]] | ||
| Line 26: | Line 24: | ||
*[[Apolipoprotein C2|Apolipoprotein C2 deficiency]] | *[[Apolipoprotein C2|Apolipoprotein C2 deficiency]] | ||
*[[Apolipoprotein E|Apoliprotein E deficiency]] | *[[Apolipoprotein E|Apoliprotein E deficiency]] | ||
*[[ | *[[Autosomal recessive hypercholesterolemia]] | ||
*[[Beta blockers]] | *[[Beta blockers]] | ||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[Binge eating disorder]] | *[[Binge eating disorder]] | ||
*[[Chronic kidney disease]] | *[[Chronic kidney disease]] | ||
*[[Corticosteroids]] | *[[Corticosteroids]] | ||
*[[Cyclosporine]] | *[[Cyclosporine]] | ||
*[[Estrogens]] | *[[Estrogens]] | ||
*[[Everolimus]] | *[[Everolimus]] | ||
*[[Familial combined | *[[Familial combined hyperlipidemia]] | ||
*[[Familial hypercholesterolemia]] | *[[Familial hypercholesterolemia]] | ||
*[[Glycogen storage disease type 1a]] | |||
*[[Glycogen storage disease | *[[Glycogenosis type 3]] | ||
*[[Glycogenosis type 3]] | |||
*[[Glycogenosis type 6]] | *[[Glycogenosis type 6]] | ||
*[[Hyperlipoproteinemia|Familial hyperlipoproteinemia type 5]] | *[[Hyperlipoproteinemia|Familial hyperlipoproteinemia type 5]] | ||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
*[[Lack of physical inactivity ]] | |||
*[[Lecithin cholesterol acyltransferase deficiency]] | *[[Lecithin cholesterol acyltransferase deficiency]] | ||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[Lipoprotein lipase deficiency]] | |||
*[[Nephrotic syndrome]] | *[[Nephrotic syndrome]] | ||
*[[Niemann-Pick disease type B]] | *[[Niemann-Pick disease, type B ]] | ||
*[[Obesity]] | *[[Obesity]] | ||
*[[Olanzapine]] | *[[Olanzapine]] | ||
*[[Polycystic ovary syndrome]] | *[[Polycystic ovary syndrome]] | ||
| Line 55: | Line 52: | ||
*[[Primary biliary cirrhosis]] | *[[Primary biliary cirrhosis]] | ||
*[[Sirolimus]] | *[[Sirolimus]] | ||
*[[Temsirolimus]] | *[[Temsirolimus]] | ||
*[[Thiazide diuretics | *[[Thiazide diuretics ]] | ||
*[[Tofacitinib]] | *[[Tofacitinib]] | ||
*[[Zieve's syndrome]] | *[[Zieve's syndrome]] | ||
{{col-end}} | {{col-end}} | ||
| Line 84: | Line 77: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Cyclosporine]], [[estrogens]], [[everolimus]], [[olanzapine]], [[sirolimus]], [[temsirolimus]], [[thiazide diuretics ]], [[tofacitinib]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 92: | Line 85: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Diabetes mellitus]], [[metabolic syndrome]], [[polycystic ovary syndrome]],[[hypothyroidism]], | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 100: | Line 93: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
|bgcolor="Beige"| [[Glycogenosis type 6]], [[Niemann-Pick disease type B ]], [[primary biliary cirrhosis]], [[Stauffer syndrome]], [[Zieve's syndrome]] | |bgcolor="Beige"| [[Glycogenosis type 3]], [[glycogenosis type 6]], [[Niemann-Pick disease type B ]], [[primary biliary cirrhosis]], [[Stauffer syndrome]], [[Zieve's syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Analbuminaemia]], [[apo A-I deficiency]], [[apolipoprotein B deficiency]], [[apolipoprotein c2|apolipoprotein C2 deficiency]], [[apoliprotein e|apoliprotein E deficiency]], [[familial hypercholesterolemia|autosomal recessive hypercholesterolemia]], [[familial combined hyperlipidemia]], [[familial hypercholesterolemia]], [[glycogen storage disease type 1a]], [[glycogenosis type 3]], [[glycogenosis type 6]], [[hyperlipoproteinemia|familial hyperlipoproteinemia type 5]], [[lecithin cholesterol acyltransferase deficiency]], [[lipoprotein lipase deficiency]], [[Niemann-Pick disease type B]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 120: | Line 113: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal/Orthopedic''' | | '''Musculoskeletal/Orthopedic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[ Berardinelli–Seip syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Apo A-I deficiency]], [[apoliprotein E deficiency]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"|[[Metabolic syndrome]], [[ Niemann-Pick disease type B]], [[obesity]], [[Zieve's syndrome]] | |bgcolor="Beige"|[[Metabolic syndrome]], [[ Niemann-Pick disease type B]], [[obesity]], [[Zieve's syndrome]],[[Berardinelli–seip syndrome]], [[analbuminaemia]], [[diabetes mellitus]], [[diabetes mellitus]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Polycystic ovary syndrome]], [[pregnancy]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 140: | Line 133: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Ophthalmologic''' | | '''Ophthalmologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Alström syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 148: | Line 141: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Psychiatric''' | | '''Psychiatric''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Binge eating disorder]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 156: | Line 149: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Renal/Electrolyte''' | | '''Renal/Electrolyte''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Chronic kidney disease]], [[nephrotic syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[hashimoto's thyroiditis ]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 176: | Line 169: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Lack of physical inactivity ]]|- | ||
|- | |||
|} | |} | ||
| Line 183: | Line 175: | ||
{{col-begin|width=80%}} | {{col-begin|width=80%}} | ||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
* | *[Apo A-I deficiency]] | ||
*[[Alagille syndrome]] | *[[Alagille syndrome]] | ||
*[[Alström syndrome]] | *[[Alström syndrome]] | ||
| Line 192: | Line 183: | ||
*[[Apolipoprotein C2|Apolipoprotein C2 deficiency]] | *[[Apolipoprotein C2|Apolipoprotein C2 deficiency]] | ||
*[[Apolipoprotein E|Apoliprotein E deficiency]] | *[[Apolipoprotein E|Apoliprotein E deficiency]] | ||
*[[ | *[[Autosomal recessive hypercholesterolemia]] | ||
*[[Beta blockers]] | *[[Beta blockers]] | ||
*[[Binge eating disorder]] | *[[Binge eating disorder]] | ||
*[[ | *[[Berardinelli–seip syndrome ]] | ||
*[[Chronic kidney disease]] | *[[Chronic kidney disease]] | ||
*[[Corticosteroids]] | *[[Corticosteroids]] | ||
*[[Cyclosporine]] | *[[Cyclosporine]] | ||
{{col-break|width=33%}} | |||
*[[Diabetes mellitus]] | *[[Diabetes mellitus]] | ||
*[[Estrogens]] | *[[Estrogens]] | ||
*[[Everolimus]] | *[[Everolimus]] | ||
*[[Familial combined | *[[Familial combined hyperlipidemia]] | ||
*[[Familial hypercholesterolemia]] | *[[Familial hypercholesterolemia]] | ||
*[[Glycogen storage disease type 1a]] | |||
*[[Glycogenosis type 3]] | |||
*[[Glycogenosis type 6]] | |||
*[[Hypothyroidism]] | |||
*[[Hyperlipoproteinemia|Familial hyperlipoproteinemia type 5]] | *[[Hyperlipoproteinemia|Familial hyperlipoproteinemia type 5]] | ||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
*[[Hashimoto's thyroiditis ]] | *[[Hashimoto's thyroiditis ]] | ||
*[[ | *[[Lack of physical inactivity ]] | ||
*[[Lecithin cholesterol acyltransferase deficiency]] | *[[Lecithin cholesterol acyltransferase deficiency]] | ||
{{col-break|width=33%}} | |||
*[[Lipoprotein lipase deficiency]] | *[[Lipoprotein lipase deficiency]] | ||
*[[Metabolic syndrome ]] | *[[Metabolic syndrome ]] | ||
*[[Nephrotic syndrome]] | *[[Nephrotic syndrome]] | ||
*[[Niemann-Pick disease type B]] | *[[Niemann-Pick disease, type B ]] | ||
*[[Obesity]] | *[[Obesity]] | ||
*[[Olanzapine]] | *[[Olanzapine]] | ||
| Line 226: | Line 216: | ||
*[[Primary biliary cirrhosis]] | *[[Primary biliary cirrhosis]] | ||
*[[Sirolimus]] | *[[Sirolimus]] | ||
*[[Temsirolimus]] | *[[Temsirolimus]] | ||
*[[Thiazide diuretics | *[[Thiazide diuretics ]] | ||
*[[Tofacitinib]] | *[[Tofacitinib]] | ||
*[[Zieve's syndrome]] | *[[Zieve's syndrome]] | ||
{{col-end}} | {{col-end}} | ||
Revision as of 19:44, 19 September 2013
|
Cholesterol Microchapters |
|
Clinical Correlation |
|---|
|
Treatment |
|
Case Studies |
|
High cholesterol causes On the Web |
|
American Roentgen Ray Society Images of High cholesterol causes |
|
Risk calculators and risk factors for High cholesterol causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
High cholesterol level can result from various causes which include: genetic (e.g. apo A-I deficiency, apolipoprotein B deficiency, apolipoprotein C2 deficiency, apoliprotein E deficiency, autosomal recessive hypercholesterolemia, familial combined hyperlipidemia, familial hypercholesterolemia); side effect of medications (e.g. antiretroviral therapy, beta blockers, corticosteroids); metabolic (e.g. metabolic syndrome, Niemann-Pick disease type B, obesity, Zieve's syndrome), endocrine (e.g. polycystic ovary syndrome, Werner syndrome) and many other conditions.